Update On Acute Stroke & Preventive Management – Salman Azhar, MD

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack 

2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association

CNS Inflammatory Disorders – Daniel Gratch, MD

Defining the clinical course of multiple sclerosis: Results of an international survey

Rationale and Pipeline for Tau-directed Therapeutics in Alzheimer’s Disease and other Tauopathies – Luca Giliberto, MD, PhD

Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition

Revisiting the therapeutic landscape of tauopathies: assessing the current pipeline and clinical trials

AAV-mediated peripheral scFv’s administration to reduce cerebral tau in adult P301S transgenic mice: Mono-vs. combination therapy

Current Status of Clinical Trials on Tau Immunotherapies

Oligonucleotide therapeutics for neurodegenerative diseases

Clinical Manifestations of Brain Inflammation – Souhel Najjar, MD

A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis

Parkinson’s Talk – Noah Kieffer, PA

Initiation of pharmacological therapy in Parkinson’s disease: when, why, and how

Interventional Stroke Treatment – Richard Jung, MD

2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association

An Update on Epilepsy: Diagnostics & Treatments – Anna Bank, MD